Immunization with heat shock protein 105-pulsed dendritic cells leads to tumor rejection in mice

Biochemical and Biophysical Research Communications

Volumn 343, Issue 1, 2006, Pages 269-278

  Yokomine, Kazunori ^a   Nakatsura, Tetsuya ^a,c   Minohara, Motozumi ^b   Kira, Jun Ichi ^b   Kubo, Tatsuko ^a   Sasaki, Yutaka ^a   Nishimura, Yasuharu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Cancer antigen; CTL; Dendritic cells; Heat shock protein 105; Th

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 105; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFECT; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR REJECTION; VACCINATION;

ADOPTIVE TRANSFER; ANIMALS; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DENDRITIC CELLS; HSP110 HEAT-SHOCK PROTEINS; IMMUNIZATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED STRAINS; NEOPLASMS; VACCINATION;

ANIMALIA;

EID: 33645100231     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.142     Document Type: Article

References (40)

1. M.E. Feder, and G.E. Hofmann Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology Annu. Rev. Physiol. 61 1999 243 282
2. P. Srivastava Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses Annu. Rev. Immunol. 20 2002 395 425
3. H. Udono, and P.K. Srivastava Heat shock protein 70-associated peptides elicit specific cancer immunity J. Exp. Med. 178 1993 1391 1396
4. Y. Tamura, P. Peng, K. Liu, M. Daou, and P.K. Srivastava Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations Science 278 1997 117 120
5. G. Parmiani, A. Testori, M. Maio, C. Castelli, L. Rivoltini, L. Pilla, F. Belli, V. Mazzaferro, J. Coppa, R. Patuzzo, M.R. Sertoli, A. Hoos, P.K. Srivastava, and M. Santinami Heat shock proteins and their use as anticancer vaccines Clin. Cancer Res. 10 2004 8142 8146
6. J.M. Timmerman, and R. Levy Dendritic cell vaccines for cancer immunotherapy Annu. Rev. Med. 50 1999 507 529
7. + T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells J. Exp. Med. 187 1998 1555 1564
8. C. Kurts, W.R. Heath, F.R. Carbone, J. Allison, J.F. Miller, and H. Kosaka Constitutive class I-restricted exogenous presentation of self antigens in vivo J. Exp. Med. 184 1996 923 930
9. F. Castellino, P.E. Boucher, K. Eichelberg, M. Mayhew, J.E. Rothman, A.N. Houghton, and R.N. Germain Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways J. Exp. Med. 191 2000 1957 1964
10. R.J. Binder, D.K. Han, and P.K. Srivastava CD91: a receptor for heat shock protein gp96 Nat. Immunol. 1 2000 151 155
11. T. Nakatsura, S. Senju, K. Yamada, T. Jotsuka, M. Ogawa, and Y. Nishimura Gene cloning of immunogenic antigens overexpressed in pancreatic cancer Biochem. Biophys. Res. Commun. 281 2001 936 944
12. M. Kai, T. Nakatsura, H. Egami, S. Senju, Y. Nishimura, and M. Ogawa Heat shock protein 105 is overexpressed in a variety of human tumors Oncol. Rep. 10 2003 1777 1782
13. + T cells Cancer Sci. 96 2005 695 705
14. H. Singh-Jasuja, H.U. Scherer, N. Hilf, D. Arnold-Schild, H.G. Rammensee, R.E. Toes, and H. Schild The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor Eur. J. Immunol. 30 2000 2211 2215
15. S.B. Flohé, J. Brüggemann, S. Lendemans, M. Nikulina, G. Meierhoff, S. Flohé, and H. Kolb Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype J. Immunol. 170 2003 2340 2348
16. + cells in vivo J. Immunol. 165 2000 6029 6035
17. H. Bausinger, D. Lipsker, U. Ziylan, S. Manié, J.P. Briand, J.P. Cazenave, S. Muller, J.F. Haeuw, C. Ravanat, H. de la Salle, and D. Hanau Endotoxin-free heat-shock protein70 fails to induce APC activation Eur. J. Immunol. 32 2002 3708 3713
18. N. Yamagishi, H. Nishihori, K. Ishihara, K. Ohtsuka, and T. Hatayama Modulation of the chaperone activities of Hsc70/Hsp40 by Hsp105α and Hsp105β Biochem. Biophys. Res. Commun. 272 2000 850 855
19. M. Minohara, H. Ochi, S. Matsushita, A. Irie, Y. Nishimura, and J. Kira Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls Tissue antigens 57 2001 447 456
20. T. Nakatsura, H. Komori, T. Kubo, Y. Yoshitake, S. Senju, T. Katagiri, Y. Furukawa, M. Ogawa, Y. Nakamura, and Y. Nishimura Mouse homologue of a novel human oncofetal antigen, Glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reaction in mice Clin. Cancer Res. 10 2004 8630 8640
21. S. Senju, S. Hirata, H. Matsuyoshi, M. Masuda, Y. Uemura, K. Araki, K. Yamamura, and Y. Nishimura Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells Blood 101 2003 3501 3508
22. H. Matsuyoshi, S. Senju, S. Hirata, Y. Yoshitake, Y. Uemura, and Y. Nishimura Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination J. Immunol. 172 2004 776 786
23. + T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms Eur. J. Immunol. 28 1998 305 316
24. E.A. Craig, J.S. Weissman, and A.L. Horwich Heat shock proteins and molecular chaperones: mediators of protein conformation and turnover in the cell Cell 78 1994 365 372
25. K. Yasuda, A. Nakai, T. Hatayama, and K. Nagata Cloning and expression of murine high molecular mass heat shock proteins, HSP105 J. Biol. Chem. 270 1995 29718 29723
26. D. Lee-Yoon, D. Easton, M. Murawski, R. Burd, and J.R. Subjeck Identification of a major subfamily of large hsp70-like proteins through the cloning of the mammalian 110-kDa heat shock protein J. Biol. Chem. 270 1995 15725 15733
27. X.Y. Wang, L. Kazim, E.A. Repasky, and J.R. Subjeck Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity J. Immunol. 165 2001 490 497
28. X.Y. Wang, X. Chen, M.H. Manjili, E. Repasky, R. Henderson, and J.R. Subjeck Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100 Cancer Res. 63 2003 2553 2560
29. C.V. Nicchitta Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity Nat. Rev. Immunol. 3 2003 427 432
30. H.D. Hickman-Miller, and W.H. Hildebrand The immune response under stress: the role of HSP-derived peptides Trends Immunol. 25 2004 427 433
31. K. Azuma, S. Shichijo, H. Takedatsu, N. Komatsu, H. Sawamizu, and K. Itoh Heat shock cognate protein 70 encodes antigenic epitopes recognized by HLA-B4601-restricted cytotoxic T lymphocytes from cancer patients Br. J. Cancer 89 2003 1079 1085
32. O. Faure, S. Graff-Dubois, L. Bretaudeau, L. Derré, D.A. Gross, P.M. Alves, S. Cornet, M.T. Duffour, S. Chouaib, I. Miconnet, M. Gregoire, F. Jotereau, F.A. Lemonnier, J.P. Abastado, and K. Kosmatopoulos Inducible HSP70 as target of anticancer immunotherapy: identification of HLA-A*0201- restricted epitopes Int. J. Cancer 108 2004 863 870
33. + T cells in the antitumor immune response J. Exp. Med. 188 1998 2357 2368
34. S.A. Rosenberg, J.C. Yang, and N.P. Restifo Cancer immunotherapy: moving beyond current vaccines Nat. Med. 10 2004 909 915
35. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
36. M. Bellone, D. Cantarella, P. Castiglioni, M.C. Crosti, A. Ronchetti, M. Moro, M.P. Garancini, G. Casorati, and P. Dellabona Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma J. Immunol. 165 2000 2651 2656
37. M.L. Albert, B. Sauter, and N. Bhardwaj Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature 392 1998 86 89
38. E. Noessner, R. Gastpar, V. Milani, A. Brandl, P.J. Hutzler, M.C. Kuppner, M. Roos, E. Kremmer, A. Asea, S.K. Calderwood, and R.D. Issels Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells J. Immunol. 169 2002 5424 5432
39. H. Singh-Jasuja, R.E. Toes, P. Spee, C. Münz, N. Hilf, S.P. Schoenberger, P. Ricciardi-Castagnoli, J. Neefjes, H.G. Rammensee, D. Arnold-Schild, and H. Schild Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis J. Exp. Med. 191 2000 1965 1974
40. L.L. Cavanagh, R. Bonasio, I.B. Mazo, C. Halin, G. Cheng, A.W. van der Velden, A. Cariappa, C. Chase, P. Russell, M.N. Starnbach, P.A. Koni, S. Pillai, W. Weninger, and U.H. von Andrian Activating of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells Nat. Immunol. 6 2005 1029 1037